| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1068965224 |
| P356 | DOI | 10.2119/MOLMED.2009.00119 |
| P932 | PMC publication ID | 2829614 |
| P698 | PubMed publication ID | 20200618 |
| P5875 | ResearchGate publication ID | 41722426 |
| P50 | author | Roberta Russo | Q37829988 |
| Mario Capasso | Q37829998 | ||
| Natalia Rosso | Q37838341 | ||
| Massimo Roncalli | Q37839163 | ||
| Luigi Tornillo | Q40856429 | ||
| Claudio Tiribelli | Q41817157 | ||
| P2093 | author name string | Daniela Spano | |
| Achille Iolascon | |||
| Luigi M Terracciano | |||
| Vittorio Di Maso | |||
| P2860 | cites work | Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma | Q83118257 |
| The estrogen-responsive B box protein: a novel regulator of keratinocyte differentiation | Q24292715 | ||
| The estrogen-responsive B box protein: a novel enhancer of interleukin-1beta secretion | Q24312686 | ||
| Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma | Q24314663 | ||
| The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation | Q24317091 | ||
| The estrogen-responsive B box protein is a novel regulator of the retinoid signal | Q24319942 | ||
| Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones | Q24532164 | ||
| Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer | Q24681820 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Summaries of Affymetrix GeneChip probe level data | Q27860888 | ||
| Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors | Q28143666 | ||
| Galectins and cancer | Q28201134 | ||
| 90K (Mac-2 BP) and galectins in tumor progression and metastasis | Q28242012 | ||
| The role of adhesion molecules, alpha v beta 3, alpha v beta 5 and their ligands in the tumor cell and endothelial cell adhesion | Q28261581 | ||
| An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division | Q28299789 | ||
| Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
| The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Q29547915 | ||
| Management of hepatocellular carcinoma | Q29616230 | ||
| Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 | ||
| Growth of human hepatoma cells lines with differentiated functions in chemically defined medium | Q29617962 | ||
| Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer | Q33274095 | ||
| Comparative proteomic expression profile in all-trans retinoic acid differentiated neuroblastoma cell line | Q33287185 | ||
| Management of hepatocellular carcinoma. | Q33993264 | ||
| The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation | Q34134233 | ||
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma. | Q34235518 | ||
| Subcellular localization of moesin in dynamic filopodia, retraction fibers, and other structures involved in substrate exploration, attachment, and cell-cell contacts | Q34301673 | ||
| Galectins as modulators of tumour progression | Q34381235 | ||
| Hepatocellular carcinoma--cause, treatment and metastasis | Q34512068 | ||
| A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. | Q34579605 | ||
| Genetic mechanisms of hepatocarcinogenesis | Q34611410 | ||
| Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases | Q34630689 | ||
| The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer | Q34708251 | ||
| Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy | Q35127584 | ||
| A decade's studies on metastasis of hepatocellular carcinoma | Q35611503 | ||
| PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer | Q35886689 | ||
| The roles of aldo-keto reductases in steroid hormone action. | Q36006584 | ||
| The ZIC gene family in development and disease. | Q36055612 | ||
| Galectin-1 as a potential cancer target | Q36078029 | ||
| Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism | Q36383370 | ||
| Matrix metalloproteinases and tumor metastasis | Q36471104 | ||
| The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer | Q36477169 | ||
| Emerging roles for zic genes in early development | Q36748446 | ||
| Ezrin/radixin/moesin: versatile controllers of signaling molecules and of the cortical cytoskeleton | Q36785712 | ||
| Focal gains of VEGFA and molecular classification of hepatocellular carcinoma | Q36984575 | ||
| Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer | Q37032635 | ||
| Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling | Q37446845 | ||
| Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. | Q55476008 | ||
| The biology of the opioid growth factor receptor (OGFr) | Q55954264 | ||
| Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas | Q62091891 | ||
| Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors | Q62091898 | ||
| Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma | Q63446362 | ||
| Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium | Q68947147 | ||
| Protein secretion of human cultured liver cells | Q69138457 | ||
| Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis | Q71688593 | ||
| Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients | Q73420860 | ||
| Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies | Q73490475 | ||
| Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer | Q73644483 | ||
| Differential expression of galectin 3 and galectin 1 in colorectal cancer progression | Q73933595 | ||
| Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1 | Q78127337 | ||
| Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion | Q79097251 | ||
| Cytokine gene polymorphisms in Italian preterm infants: association between interleukin-10 -1082 G/A polymorphism and respiratory distress syndrome | Q79809826 | ||
| Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression | Q80516687 | ||
| Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma | Q38304400 | ||
| Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures. | Q39840008 | ||
| Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness. | Q39861429 | ||
| Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons | Q39874836 | ||
| Paracrine-stimulated gene expression profile favors estradiol production in breast tumors | Q40273768 | ||
| Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray | Q40359916 | ||
| Expression of developmentally regulated endothelial cell locus 1 was induced by tumor-derived factors including VEGF. | Q40407711 | ||
| Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements | Q40617232 | ||
| Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma | Q40817943 | ||
| Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinomas | Q41591167 | ||
| Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines | Q41720805 | ||
| Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications | Q41786603 | ||
| Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma | Q41918713 | ||
| Differential expression of galectin-1 and galectin-3 during first trimester human embryogenesis | Q42443034 | ||
| Expression of galectins in head and neck squamous cell carcinoma | Q42525183 | ||
| Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas | Q43011700 | ||
| Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin | Q44370346 | ||
| Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate | Q45176154 | ||
| Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation | Q45244862 | ||
| Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarray | Q45533582 | ||
| Apoptosis of T cells mediated by galectin-1. | Q46356564 | ||
| AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer | Q46842961 | ||
| Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors | Q46897705 | ||
| CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma. | Q47236344 | ||
| Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases | Q48543365 | ||
| Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma | Q48958266 | ||
| Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. | Q52087746 | ||
| Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. | Q52831788 | ||
| Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. | Q53613815 | ||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 102-115 | |
| P577 | publication date | 2009-12-21 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness | |
| P478 | volume | 16 |
| Q38028882 | Animal lectins: potential antitumor therapeutic targets in apoptosis |
| Q41334598 | Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression |
| Q38985159 | Evaluation of cytotoxicity and DNA damage response with analysis of intracellular ATM signaling pathways |
| Q38831575 | Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells |
| Q48270428 | Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives |
| Q53284113 | Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells. |
| Q33631354 | Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma |
| Q58574738 | Galectin-1 gene silencing inhibits the activation and proliferation but induces the apoptosis of hepatic stellate cells from mice with liver fibrosis |
| Q34103149 | Galectin-1 is part of human trophoblast invasion machinery--a functional study in vitro. |
| Q46011748 | Galectin-1 promotes tumor progression via NF-κB signaling pathway in epithelial ovarian cancer. |
| Q38932655 | Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells |
| Q35713459 | Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma |
| Q38728270 | Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line. |
| Q91610628 | Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver |
| Q35970148 | Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression |
| Q36972087 | Hepatocyte polarity |
| Q38174863 | Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma |
| Q47737163 | Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database |
| Q39026528 | In vitro selection of the 3'-untranslated regions of the human liver mRNA that bind to the HCV nonstructural protein 5B. |
| Q45885229 | Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis |
| Q35016956 | Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction |
| Q36545014 | LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression |
| Q37636762 | MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma |
| Q39578275 | Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. |
| Q35111396 | Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma |
| Q36149299 | Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma |
| Q38714509 | The NmrA-like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial-mesenchymal transition |
| Q50101341 | The emerging role of galectins in high-fatality cancers |
| Q37831426 | The immunoregulatory mechanisms of carcinoma for its survival and development |
Search more.